File #004: Paramedics, Pipelines & Phase 4: Doug Schantz on Steering Global Clinical Ops
Impossible d'ajouter des articles
Désolé, nous ne sommes pas en mesure d'ajouter l'article car votre panier est déjà plein.
Veuillez réessayer plus tard
Veuillez réessayer plus tard
Échec de l’élimination de la liste d'envies.
Veuillez réessayer plus tard
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
File #004: Paramedics, Pipelines & Phase 4: Doug Schantz on Steering Global Clinical Ops
-
Lu par :
-
De :
À propos de ce contenu audio
Veteran clinical-operations leader Doug Schantz joins Clinical Trial Files to trace a career that spans emergency-room stretchers and first-in-human gene-therapy trials. In this lively conversation Doug unpacks:
- how a paramedic’s mindset shaped his approach to Phase 1-4 global programs at Pfizer, AstraZeneca, Alexion, and AskBio;
- the biggest headaches—and hidden advantages—of running studies across borders and therapy areas (oncology, neuroscience, cardiovascular, rare disease, gene therapy);
- practical lessons on in-house vs. outsourced monitoring, risk-based quality management, and building site relationships that last;
- the future of gene-therapy trials—and the three traits he’d engineer into a “perfect” clinical site;
Whether you’re running your first study or steering an entire portfolio, Doug’s candor and hard-won playbook will leave you with fresh tactics—and a few laughs—to bring back to your own trials.
👉 Subscribe for new episodes every 2nd and 4th Wednesday, and share your thoughts with #ClinicalTrialFiles on LinkedIn
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !
Aucun commentaire pour le moment